ESR1 and breast cancer: In vitro, Sulforaphane has been found to reduce the size and number of primary mammospheres in SUM159 and MCF7 breast cancer cells, which are TNBC and ER+, respectively, while downregulating VEGF and HIF-1α in breast cancer cells [70].